FOLD icon

Amicus Therapeutics

216 hedge funds and large institutions have $2.81B invested in Amicus Therapeutics in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 87 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

19% less capital invested

Capital invested by funds: $3.48B → $2.81B (-$666M)

26% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 87

Holders
216
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.56M
Puts
$2.56M
Net Calls
Net Calls Change

Top Buyers

1 +$54.6M
2 +$33.9M
3 +$18.9M
4
State Street
State Street
Massachusetts
+$13.6M
5
PA
Perceptive Advisors
New York
+$9.44M

Top Sellers

1 -$19.4M
2 -$18.9M
3 -$17.2M
4
Two Sigma Investments
Two Sigma Investments
New York
-$11.2M
5
GH
Grosvenor Holdings
Illinois
-$11.1M
Name Holding Trade Value Shares
Change
Change in
Stake
151
$153K
152
$147K
153
$144K
154
$143K
155
$127K
156
$121K
157
$120K
158
$118K
159
$115K
160
$111K
161
$111K
162
$109K
163
$103K
164
$101K
165
$101K
166
$99K
167
$99K
168
$97K
169
$95K
170
$88K
171
$81K
172
$62K
173
$57K
174
$55K
175
$50K